Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated. | Eur Heart J;44(42): 4485-4487, 2023 11 07. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated.

Tamargo, Juan; Agewall, Stefan.

Affiliation

Tamargo J; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense, Instituto Gregorio Marañón, 28049 Madrid, Spain.
Agewall S; Faculty of Medicine, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden.

Eur Heart J ; 44(42): 4485-4487, 2023 11 07.

Article in En | MEDLINE | ID: mdl-37862581

Subject(s)

Aortic Aneurysm; Fluoroquinolones; Humans; Fluoroquinolones/adverse effects; Aortic Aneurysm/chemically induced; Anti-Bacterial Agents/adverse effects

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aortic Aneurysm / Fluoroquinolones Limits: Humans Language: En Journal: Eur Heart J Year: 2023 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aortic Aneurysm / Fluoroquinolones Limits: Humans Language: En Journal: Eur Heart J Year: 2023 Document type: Article